InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
12
T+90 hit rate
53%
T+90 mean return
+15.2%
Across 32 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Grossman Adam S, Chief Executive Officer. Insider active across 1 company, notably Adma Biologics, INC.. Aggregated, 54 reports have been logged. Breakdown: 2 buys · 12 sells. Total volume traded: €13.1m. History available since 29 September 2021. The latest transaction was filed on 16 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations54 total
15,000 shares@ US$5.400.0037% mcap0.3% of flowCommon StockSEC:0001140361-26-009899:0
15,000 shares@ US$15.160.010% mcap0.9% of flowCommon StockSEC:0001140361-26-009899:1
6,000 shares@ US$15.160.0041% mcap0.3% of flowCommon StockSEC:0001140361-26-009899:2
56,438 shares@ US$15.390.039% mcap3.3% of flowCommon StockSEC:0001140361-26-008904:0
29,513 shares@ US$15.390.020% mcap1.7% of flowCommon StockSEC:0001140361-26-008904:1
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-26-005888:0
15,000 shares@ US$16.080.9% of flowCommon StockSEC:0001140361-26-005888:1
6,000 shares@ US$16.080.4% of flowCommon StockSEC:0001140361-26-005888:2
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-045737:0
15,000 shares@ US$19.791.1% of flowCommon StockSEC:0001140361-25-045737:1
6,000 shares@ US$19.790.4% of flowCommon StockSEC:0001140361-25-045737:2
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-035159:0
15,000 shares@ US$16.130.9% of flowCommon StockSEC:0001140361-25-035159:1
6,000 shares@ US$16.130.4% of flowCommon StockSEC:0001140361-25-035159:2
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-019589:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-014267:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-009928:0
56,438 shares@ US$16.913.8% of flowCommon StockSEC:0001140361-25-007924:0
18,018 shares@ US$15.441.2% of flowCommon StockSEC:0001140361-25-006386:0
252,022 shares0Common StockSEC:0001140361-25-005534:0
14,343 shares@ US$17.151.0% of flowCommon StockSEC:0001140361-25-000270:0
48,967 shares@ US$21.104.3% of flowCommon StockSEC:0001140361-24-047701:0
21,752 shares@ US$19.991.7% of flowCommon StockSEC:0001140361-24-042641:0
64,405 shares@ US$3.350.8% of flowCommon StockSEC:0001140361-24-038772:0
55,000 shares@ US$5.001.1% of flowCommon StockSEC:0001140361-24-038772:1
25 of 54 declarations
About Grossman Adam S
Adam S. Grossman is the President and CEO of ADMA BIOLOGICS, INC. He leads the company and is responsible for implementing the overall strategy. Adam plays a key role in directing operations and developing new biological products.
